Mather Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $652K | Sell |
1,607
-705
| -30% | -$286K | 0.01% | 335 |
|
|
2025
Q1 | $1.15M | Sell |
2,312
-113
| -5% | -$56.2K | 0.01% | 239 |
|
|
2024
Q4 | $1.26M | Sell |
2,425
-345
| -12% | -$179K | 0.02% | 212 |
|
|
2024
Q3 | $1.71M | Sell |
2,770
-404
| -13% | -$250K | 0.02% | 180 |
|
|
2024
Q2 | $1.84M | Buy |
3,174
+745
| +31% | +$433K | 0.02% | 197 |
|
|
2024
Q1 | $1.29M | Sell |
2,429
-670
| -22% | -$356K | 0.02% | 194 |
|
|
2023
Q4 | $1.64M | Buy |
3,099
+163
| +6% | +$86.5K | 0.03% | 172 |
|
|
2023
Q3 | $1.49M | Buy |
2,936
+408
| +16% | +$206K | 0.03% | 167 |
|
|
2023
Q2 | $1.32M | Sell |
2,528
-929
| -27% | -$485K | 0.02% | 191 |
|
|
2023
Q1 | $1.99M | Buy |
3,457
+1,059
| +44% | +$610K | 0.04% | 149 |
|
|
2022
Q4 | $1.32M | Buy |
2,398
+482
| +25% | +$265K | 0.03% | 172 |
|
|
2022
Q3 | $972K | Sell |
1,916
-322
| -14% | -$163K | 0.02% | 201 |
|
|
2022
Q2 | $1.22M | Buy |
2,238
+576
| +35% | +$313K | 0.03% | 162 |
|
|
2022
Q1 | $981K | Buy |
1,662
+481
| +41% | +$284K | 0.02% | 174 |
|
|
2021
Q4 | $788K | Sell |
1,181
-516
| -30% | -$344K | 0.02% | 171 |
|
|
2021
Q3 | $970K | Buy |
1,697
+918
| +118% | +$525K | 0.02% | 118 |
|
|
2021
Q2 | $393K | Buy |
779
+23
| +3% | +$11.6K | 0.01% | 184 |
|
|
2021
Q1 | $345K | Buy |
756
+73
| +11% | +$33.3K | 0.01% | 190 |
|
|
2020
Q4 | $318K | Buy |
683
+55
| +9% | +$25.6K | 0.01% | 182 |
|
|
2020
Q3 | $277K | Buy |
+628
| New | +$277K | 0.01% | 190 |
|